These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27786589)
1. Current management of severe dengue infection. Lee TH; Lee LK; Lye DC; Leo YS Expert Rev Anti Infect Ther; 2017 Jan; 15(1):67-78. PubMed ID: 27786589 [TBL] [Abstract][Full Text] [Related]
2. Dengue in the elderly: a review. Lin RJ; Lee TH; Leo YS Expert Rev Anti Infect Ther; 2017 Aug; 15(8):729-735. PubMed ID: 28730853 [TBL] [Abstract][Full Text] [Related]
3. Dengue fever: diagnosis and treatment. Wiwanitkit V Expert Rev Anti Infect Ther; 2010 Jul; 8(7):841-5. PubMed ID: 20586568 [TBL] [Abstract][Full Text] [Related]
4. Early Detection of Plasma Leakage in Dengue Hemorrhagic Fever. Nelwan EJ Acta Med Indones; 2018 Jul; 50(3):183-184. PubMed ID: 30333266 [TBL] [Abstract][Full Text] [Related]
5. Recent patents in dengue disease management. K Shahid S Pharm Pat Anal; 2020 Dec; 9(6):173-185. PubMed ID: 33350353 [TBL] [Abstract][Full Text] [Related]
6. Drugs for dengue: a patent review (2010-2014). Beesetti H; Khanna N; Swaminathan S Expert Opin Ther Pat; 2014 Nov; 24(11):1171-84. PubMed ID: 25283170 [TBL] [Abstract][Full Text] [Related]
7. Investigational drugs in early development for treating dengue infection. Beesetti H; Khanna N; Swaminathan S Expert Opin Investig Drugs; 2016 Sep; 25(9):1059-69. PubMed ID: 27322111 [TBL] [Abstract][Full Text] [Related]
8. Prospective human trials with dengue virus vaccines and the NS1 antigen production among vaccine recipients. Arya SC; Agarwal N Hum Vaccin; 2011 Dec; 7(12):1394. PubMed ID: 22108041 [No Abstract] [Full Text] [Related]
9. Current issues in dengue vaccination. Thomas SJ; Endy TP Curr Opin Infect Dis; 2013 Oct; 26(5):429-34. PubMed ID: 23963259 [TBL] [Abstract][Full Text] [Related]
10. Vaccines and immunization strategies for dengue prevention. Liu Y; Liu J; Cheng G Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365 [TBL] [Abstract][Full Text] [Related]
13. Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role. Bozzo J; Jorquera JI Expert Rev Anti Infect Ther; 2017 Jun; 15(6):585-604. PubMed ID: 28480779 [TBL] [Abstract][Full Text] [Related]
14. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach. Melino S; Paci M FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079 [TBL] [Abstract][Full Text] [Related]
15. Challenges for the formulation of a universal vaccine against dengue. Chokephaibulkit K; Perng GC Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907 [TBL] [Abstract][Full Text] [Related]
16. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Guy B; Jackson N Nat Rev Microbiol; 2016 Jan; 14(1):45-54. PubMed ID: 26639777 [TBL] [Abstract][Full Text] [Related]
17. Challenges in reducing dengue burden; diagnostics, control measures and vaccines. Lam SK Expert Rev Vaccines; 2013 Sep; 12(9):995-1010. PubMed ID: 24053394 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological intervention for dengue virus infection. Lai JH; Lin YL; Hsieh SL Biochem Pharmacol; 2017 Apr; 129():14-25. PubMed ID: 28104437 [TBL] [Abstract][Full Text] [Related]
19. Review of dengue virus and the development of a vaccine. Murrell S; Wu SC; Butler M Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601 [TBL] [Abstract][Full Text] [Related]